Everything you ever wanted to know about the HIV prevention work of EATG and AVAC.
EATG + AVAC Prevention Summit 2 Report
15/10/2015
EATG » EATG + AVAC Prevention Summit 2 Report
Newsletter / News bulletin
Latest news
Dolutegravir during pregnancy appears safe
Dolutegravir treatment does not appear to worsen pregnancy or neonatal outcomes, according to a registry study. "While the results are not conclusive because of the small number of pregnancies, neither…
Read moreART interruption with close monitoring, strict restart guidelines safe in HIV cure trials
Analytic treatment interruption, used to determine the efficacy of any therapeutic strategy designed to achieve antiretroviral therapy (ART)-free remission from HIV, caused neither expansion of HIV reservoirs nor immunologic abnormalities…
Read moreILC 2019: Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment
Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing a internationally-agreed target set by the World Health Organization, the International…
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
